---
figid: PMC3913970__2162-3619-3-4-1
figlink: /pmc/articles/PMC3913970/figure/F1/
number: Figure 1
caption: 'A schematic representation of BCR/BTK signaling pathway. The BCR consists
  of a transmembrane immunoglobulin (Ig) receptor associated with the Ig-alpha (CD79a)
  and Ig-beta (CD79b) heterodimers. The activation of BTK and PI3 kinase after antigen
  binding to BCR prompts calcium release, which leads to activation of the signaling
  cascade. BCR: B cell receptor; BTK: Bruton’s tyrosine kinase.'
pmcid: PMC3913970
papertitle: Ibrutinib for B cell malignancies.
reftext: Aileen Novero, et al. Exp Hematol Oncol. 2014;3:4-4.
pmc_ranked_result_index: '69649'
pathway_score: 0.9431813
filename: 2162-3619-3-4-1.jpg
figtitle: BCR/BTK signaling pathway
year: '2014'
organisms: Homo sapiens
ndex: f5c0a759-de8d-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3913970__2162-3619-3-4-1.html
  '@type': Dataset
  description: 'A schematic representation of BCR/BTK signaling pathway. The BCR consists
    of a transmembrane immunoglobulin (Ig) receptor associated with the Ig-alpha (CD79a)
    and Ig-beta (CD79b) heterodimers. The activation of BTK and PI3 kinase after antigen
    binding to BCR prompts calcium release, which leads to activation of the signaling
    cascade. BCR: B cell receptor; BTK: Bruton’s tyrosine kinase.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - NFKB2
  - SYK
  - REL
  - MTOR
  - PIK3R5
  - NFKB1
  - RELB
  - PIK3CD
  - PIK3R6
  - RELA
  - PIK3R3
  - LYN
  - BCR
  - PIK3CG
  - CD79B
  - PIK3CB
  - PIK3R4
  - CD79A
  - PIK3CA
  - BTK
  - Cancer
genes:
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: SYK
  symbol: SYK
  source: hgnc_symbol
  hgnc_symbol: SYK
  entrez: '6850'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: PI3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: PI3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: PI3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: LYN
  symbol: LYN
  source: hgnc_symbol
  hgnc_symbol: LYN
  entrez: '4067'
- word: BCR
  symbol: BCR
  source: hgnc_symbol
  hgnc_symbol: BCR
  entrez: '613'
- word: PI3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: IgB
  symbol: IGB
  source: hgnc_prev_symbol
  hgnc_symbol: CD79B
  entrez: '974'
- word: PI3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: Iga
  symbol: IGA
  source: hgnc_prev_symbol
  hgnc_symbol: CD79A
  entrez: '973'
- word: PI3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: BTK
  symbol: BTK
  source: hgnc_symbol
  hgnc_symbol: BTK
  entrez: '695'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
---
